AI Verdict
NTLA has stronger fundamentals based on our AI analysis.
NTRBW vs NTLA Fundamental Comparison
| Metric | NTRBW | NTLA |
|---|---|---|
| Revenue | $1.6M | $67.7M |
| Net Income | $-7.3M | $-412.7M |
| Net Margin | -443.9% | -609.9% |
| ROE | -96.2% | -61.5% |
| ROA | -86.3% | -49.0% |
| Current Ratio | 7.53x | 5.08x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-2.54 | $-3.81 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NTRBW vs NTLA: Frequently Asked Questions
Is NTRBW or NTLA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NTLA has stronger fundamentals. NTRBW is rated STRONG SELL (95% confidence) while NTLA is rated SELL (92% confidence). This is not investment advice.
How does NTRBW compare to NTLA fundamentally?
NutriBand Inc. has ROE of -96.2% vs Intellia Therapeutics, Inc.'s -61.5%. Net margins are -443.9% vs -609.9% respectively.
Which stock pays higher dividends, NTRBW or NTLA?
NTRBW has a dividend yield of N/A or no dividend while NTLA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NTRBW or NTLA for long term?
For long-term investing, consider that NTRBW has STRONG SELL rating with 95% confidence, while NTLA has SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NTRBW vs NTLA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NTRBW vs NTLA, the AI consensus favors NTLA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.